#54. Companion Diagnostic Biomarkers episode artwork

EPISODE · Apr 17, 2026 · 21 MIN

#54. Companion Diagnostic Biomarkers

from Drug Discovery AI Talk · host Dr. Jake Chen

In this episode, we outline the critical role of biomarkers and companion diagnostics (CDx) in advancing personalized medicine and streamlining drug discovery. It details how germline genetic variations help prevent adverse reactions, while somatic mutations and multi-gene expression panels allow for precise targeting of therapies, particularly within oncology. The episode emphasizes that while thousands of candidate markers exist, only those deemed essential for the safe and effective use of a specific drug achieve regulatory status as a companion diagnostic. By integrating multi-omics technologies—including proteomics and metabolomics—and AI, researchers can create more comprehensive profiles of disease biology. Ultimately, the co-development of drugs and their diagnostic counterparts is shown to increase clinical trial success rates, reduce patient toxicity, and accelerate the delivery of tailored treatments to the market. Produced by Dr. Jake Chen.

NOW PLAYING

#54. Companion Diagnostic Biomarkers

0:00 21:24

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Humanizing Change Tremendousness Join us each episode as we talk with innovators in their respective fields about their unique journeys and how they humanize change in their own work, right here, on Humanizing Change. AI Erik's Podcast Audio Erik Conn The AI News Podcast where we talk AI. CISO Perspectives (public) N2K Networks This season on CISO Perspectives, host Kim Jones explores some of the challenges of leading through uncertainty. We explore the complexity of the changing nature of regulation and working with the federal government, the evolution of privacy and fraud, and how emerging technologies like AI and quantum computing are changing cyber. When you don’t know what questions to ask, you’re afraid to ask, or don’t know who to ask, CISO Perspectives provides the foundation for learning in this brave new world. NEWMORROW SESSIONS - A PodCast Series on the Future of Hospitality Mario C. Bauer, Florian Schneider, Axel Weber & Dr. Tillman Bardt The Newmorrow PodCast is more than a podcast — it's a platform for open dialog on the future of our business, a platform for those building what doesn’t exist yet. Here, we share and embrace our passion for the hospitality industry, but we won’t romanticize the journey. We ask the tough questions, confront uncomfortable truths, and prepare for a future that resists easy answers. We believe that the tougher and wilder times become, the more openly, honestly and humanely people need to talk to each other and act together. We believe, openness, togetherness, and truthfulness should also be cornerstones of a professional community to develop our utopian idea of „open source“. This is a space where visionaries don’t just imagine the future — they wrestle with the paradoxes that shape it: success vs. happiness, data vs. instinct, stability vs. reinvention. Join leaders, entrepreneurs, and thinkers as they share not what made them — but what’s actively shaping them, now and next. So tune in

Frequently Asked Questions

How long is this episode of Drug Discovery AI Talk?

This episode is 21 minutes long.

When was this Drug Discovery AI Talk episode published?

This episode was published on April 17, 2026.

What is this episode about?

In this episode, we outline the critical role of biomarkers and companion diagnostics (CDx) in advancing personalized medicine and streamlining drug discovery. It details how germline genetic variations help prevent adverse reactions, while somatic...

Can I download this Drug Discovery AI Talk episode?

Yes, you can download this episode by clicking the download button on the episode player, or subscribe to the podcast in your preferred podcast app for automatic downloads.
URL copied to clipboard!